Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated to v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision: v3.3.1 replaces v3.2.0; no substantive changes to study content, layout, or navigation are evident in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange Detected- Removed the generic government operating status notice from the page. The remaining study details, endpoints and contact information remain unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page. The page content remains unchanged.SummaryDifference0.2%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. If no other substantive content changed, this is a minor but status/reliability-related update.SummaryDifference1%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release with updated content.SummaryDifference0.0%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.